Janesya Sutedjo;陈慧铀;姜亮;王利伟;殷信道;

• 1:南京医科大学附属南京医院(南京市第一医院)医学影像科
• 2:南京医科大学第三临床学院

摘要(Abstract)：

磁共振成像(MRI)已应用于前列腺癌(PCa)的诊断十多年。扩散加权成像(DWI)做为一种磁共振成像技术,可以在细胞水平提供定性和定量信息。DWI在提高MRI诊断前列腺癌的精确性方面可能发展成一个强大的技术。在这篇文章中,我们将介绍DWI的原理及应用基础、临床应用、局限性及应用前景。

关键词(KeyWords)： 前列腺肿瘤;弥散磁共振成像;综述文献专题

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): Janesya Sutedjo;陈慧铀;姜亮;王利伟;殷信道;

Email:

DOI:

参考文献(References)：

• [1]Stewart BW,Wild CP.World cancer report 2014.France:International Agency for Research on Cancer,2014:453-454.
• [2]Aydin H,Kizilgoz V,Tatar IG,et al.Detection of prostate cancer with magnetic resonance imaging:optimization of T1-weighted,T2-weighted,dynamic-enhanced T1-weighted,diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy,correlated with biopsy and histopathological fi ndings.J Comput Assist Tomogr,2012,36(1):30-45.
• [3]Lim KS,Tan CH.Diffusion-weighted MRI of adult male pelvic cancers.Clin Radiol,2012,67(9):899-908.
• [4]Yagci AB,Ozari N,Aybek Z,et al.The value of diffusion-weighted MRI for prostate cancer detection and localization.Diagn Interv Radiol,2011,17(2):130-134.
• [5]Abdel Maboud NM,Elsaid HH,Aboubeih EA.The role of diffusion:weighted MRI in evaluation of prostate cancer.Egyp J Radiol Nucl Med,2014,45(1):231-236.
• [6]Hekimolu B,Aydin H,Kzlgz V,et al.Identification and localization of prostate cancer with combined use of T2-weighted,diffusion weighted MRI and proton MR spectroscopy,correlation with histopathology.Adv J Mol Imaging,2013,3(3):23-36.
• [7]Hoeks CM,Barentsz JO,Hambrock T,et al.Prostate cancer:multiparametric MR imaging for detection,localization,and staging.Radiology,2011,261(1):46-66.
• [8]Haider MA,van der Kwast TH,Tanguay J,et al.Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.AJR Am J Roentgenol,2007,189(2):323-328.
• [9]Morani AC,Elsayes KM,Liu PS,et al.Abdominal applications of diffusion-weighted magnetic resonance imaging:where do we stand.World J Radiol,2013,5(3):68-80.
• [10]Kim CK,Park BK,Kim B.Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer.AJR Am J Roentgenol,2010,194(6):1461-1469.
• [11]Wang X,Qian Y,Liu B,et al.High-b-value diffusion-weighted MRI for the detection of prostate cancer at 3 T.Clin Radiol,2014,69(11):1165-1170.
• [12]Koh DM,Collins DJ.Diffusion-weighted MRI in the body:applications and challenges in oncology.AJR Am J Roentgenol,2007,188(6):1622-1635.
• [13]Thormer G,Otto J,Reiss-Zimmermann M,et al.Diagnostic value of ADC in patients with prostate cancer:infl uence of the choice of b values.Eur Radiol,2012,22(8):1820-1828.
• [14]Kwee TC,Takahara T,Ochiai R,et al.Diffusion-weighted whole-body imaging with background body signal suppression(DWIBS):features and potential applications in oncology.Eur Radiol,2008,18(9):1937-1952.
• [15]Kele PG,van der Jagt EJ.Diffusion weighted imaging in the liver.World J Gastroenterol,2010,16(13):1567-1576.
• [16]Padhani AR,Liu G,Koh DM,et al.Diffusion-weighted magnetic r e s o n a n c e i m a g i n g a s a c a n c e r b i o m a r k e r:c o n s e n s u s a n d recommendations.Neoplasia,2009,11(2):102-125.
• [17]Kim CK,Park BK,Lee HM,et al.Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil:preliminary results.Invest Radiol,2007,42(12):842-847.
• [18]Petralia G,Thoeny HC.DW-MRI of the urogenital tract:applications in oncology.Cancer Imaging,2010,10(1A):S112-S123.
• [19]Yamamura J,Salomon G,Buchert R,et al.MR imaging of prostate cancer:diffusion weighted imaging and(3D)hydrogen 1(H)MR spectroscopy in comparison with histology.Radiol Res Pract,2011,2011:616852.
• [20]Liu X,Peng W,Zhou L,et al.Biexponential apparent diffusion coeffi cients values in the prostate:comparison among normal tissue,prostate cancer,benign prostatic hyperplasia and prostatitis.Korean J Radiol,2013,14(2):222-232.
• [21]Kim CK,Park BK,Han JJ,et al.Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones:preliminary results.J Comput Assist Tomogr,2007,31(3):449-454.
• [22]Reinsberg SA,Payne GS,Riches SF,et al.Combined use of diffusionweighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.AJR Am J Roentgenol,2007,188(1):91-98.
• [23]Kitajima K,Kaji Y,Kuroda K,et al.High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate:effect of signal-to-noise ratio.Magn Reson Med Sci,2008,7(2):93-99.
• [24]Wang XZ,Wang B,Gao ZQ,et al.Diffusion-weighted imaging of prostate cancer:correlation between apparent diffusion coefficient values and tumor proliferation.J Magn Reson Imaging,2009,29(6):1360-1366.
• [25]Mazaheri Y,Shukla-Dave A,Hricak H,et al.Prostate cancer:identifi cation with combined diffusion-weighted MR imaging and 3D1H MR spectroscopic imaging--correlation with pathologic fi ndings.Radiology,2008,246(2):480-488.
• [26]Gibbs P,Pickles MD,Turnbull LW.Diffusion imaging of the prostate at 3.0 tesla.Invest Radiol,2006,41(2):185-188.
• [27]Issa B.In vivo measurement of the apparent diffusion coeffi cient in normal and malignant prostatic tissues using echo-planar imaging.J Magn Reson Imaging,2002,16(2):196-200.
• [28]Sato C,Naganawa S,Nakamura T,et al.Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coeffi cient values in transition and peripheral zones of the prostate.J Magn Reson Imaging,2005,21(3):258-262.
• [29]Kim JH,Kim JK,Park BW,et al.Apparent diffusion coefficient:prostate cancer versus noncancerous tissue according to anatomical region.J Magn Reson Imaging,2008,28(5):1173-1179.
• [30]Gibbs P,Liney GP,Pickles MD,et al.Correlation of ADC and T2measurements with cell density in prostate cancer at 3.0 Tesla.Invest Radiol,2009,44(9):572-576.
• [31]Zelhof B,Pickles M,Liney G,et al.Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer.BJU international,2009,103(7):883-888.
• [32]desouza NM,Reinsberg SA,Scurr ED,et al.Magnetic resonance imaging in prostate cancer:the value of apparent diffusion coeffi cients for identifying malignant nodules.Br J Radiol,2007,80(950):90-95.
• [33]Tanimoto A,Nakashima J,Kohno H,et al.Prostate cancer screening:the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.J Magn Reson Imaging,2007,25(1):146-152.
• [34]Wang LW,Wang M,Wang SJ,et al.The value of magnetic resonance diffusion weighted imaging in the diagnosis of prostate cancer.Chin J Magn Reson Imaging,2014,5(3):198-201.王利伟,王牧,王绍娟,等.MR扩散加权成像诊断前列腺癌的价值分析.磁共振成像,2014,5(3):198-201.
• [35]Kilickesmez O,Cimilli T,Inci E,et al.Diffusion-weighted MRI of urinary bladder and prostate cancers.Diagn Interv Radiol,2009,15(2):104-110.
• [36]Simpkin CJ,Morgan VA,Giles SL,et al.Relationship between T2relaxation and apparent diffusion coefficient in malignant and nonmalignant prostate regions and the effect of peripheral zone fractional volume.Br J Radiol,2013,86(1024):20120469.
• [37]Metens T,Miranda D,Absil J,et al.What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3 T?Eur Radiol,2012,22(3):703-709.
• [38]Kitajima K,Takahashi S,Ueno Y,et al.Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI:comparison between ultra-high b-value(2000 s/mm)and standard high b-value(1000 s/mm).J Magn Reson Imaging,2012,36(1):198-205.
• [39]Riches SF,Hawtin K,Charles-Edwards EM,et al.Diffusion-weighted imaging of the prostate and rectal wall:comparison of biexponential and monoexponential modelled diffusion and associated perfusion coeffi cients.NMR Biomed,2009,22(3):318-325.
• [40]Shinmoto H,Oshio K,Tanimoto A,et al.Biexponential apparent diffusion coeffi cients in prostate cancer.Magn Reson Imaging,2009,27(3):355-359.
• [41]Katahira K,Takahara T,Kwee TC,et al.Ultra-high-b-value diffusionweighted MR imaging for the detection of prostate cancer:evaluation in 201 cases with histopathological correlation.Eur Radiol,2011,21(1):188-196.
• [42]Rosenkrantz AB,Hindman N,Lim RP,et al.Diffusion-weighted imaging of the prostate:Comparison of b1000 and b2000 image sets for index lesion detection.J Magn Reson Imaging,2013,38(3):694-700.
• [43]Le Bihan D,Breton E,Lallemand D,et al.Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.Radiology,1988,168(2):497-505.
• [44]Shinmoto H,Tamura C,Soga S,et al.An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer.AJR Am J Roentgenol,2012,199(4):W496-W500.
• [45]Dopfert J,Lemke A,Weidner A,et al.Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging.Magn Reson Imaging,2011,29(8):1053-1058.
• [46]Takahara T,Imai Y,Yamashita T,et al.Diffusion weighted whole body imaging with background body signal suppression(DWIBS):technical improvement using free breathing,STIR and high resolution 3D display.Radiat Med,2004,22(4):275-282.
• [47]Gong JY,Zhou ZY,Deng YH,et al.The application value of whole body diffusion-weighted imaging in tumor lesions.Chin J Magn Reson Imaging,2013,4(6):420-425.龚佳英,周智洋,邓艳红,等.MR全身扩散加权成像技术在肿瘤病变中的应用价值.磁共振成像,2013,4(6):420-425.
• [48]Murtz P,Krautmacher C,Traber F,et al.Diffusion-weighted wholebody MR imaging with background body signal suppression:a feasibility study at 3.0 Tesla.Eur Radiol,2007,17(12):3031-3037.
• [49]Gurses B,Kabakci N,Kovanlikaya A,et al.Diffusion tensor imaging of the normal prostate at 3 Tesla.Eur Radiol,2008,18(4):716-721.
• [50]Wang Q,Fang JF,Wang B.Prostate cancer:theoretical base of MR diffusion tensor imaging study.Chin J Magn Reson Imaging,2015,6(1):76-80.王倩,房俊芳,王滨.磁共振扩散张量成像诊断前列腺癌的理论基础.磁共振成像,2015,6(1):76-80.